Clinical studies recruiting near Bellevue

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Nebraska Medicine-Bellevue · National Cancer Institute (NCI) · NCT05564390 A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Pa
Phase 4 · Bellevue Dermatology Clinic · Eli Lilly and Company · NCT06857942 Chronic Widespread Pain After Rapid Weight Loss in Non-Hispanic Black and Hispanic/Latino/a/x Adults
Phase N/A · New York University · NCT06795386 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Nebraska Medicine-Bellevue Medical Center · Pfizer · NCT07144280 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Nebraska Medicine-Bellevue · NRG Oncology · NCT05946213 A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Phase 2 · Northwest Clinical Research Center · Eli Lilly and Company · NCT05986292 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · FHCC Overlake · NRG Oncology · NCT05174169 Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Phase 2 · Clinical Site · Intra-Cellular Therapies, Inc. · NCT06480383 A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Phase 4 · Washington Gastroenterology- GIA · Takeda · NCT06095128 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Nebraska Medicine-Bellevue · Alliance for Clinical Trials in Oncology · NCT06876714 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · FHCC Overlake · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · FHCC Overlake · Canadian Cancer Trials Group · NCT06592924 Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Phase 2 · Clinical Site · Intra-Cellular Therapies, Inc. · NCT06701903 Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggress
Phase 2 · Nebraska Medicine-Bellevue · National Cancer Institute (NCI) · NCT06649812 A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary
Phase 3 · Pacific Northwest Retina (Bellevue) · Kodiak Sciences Inc · NCT06990399 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Nebraska Medicine-Bellevue · Alliance for Clinical Trials in Oncology · NCT04242095 A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Trea
Phase 2 · Seattle Neuropsychiatric Treatment Center · atai Therapeutics, Inc. · NCT06524830 Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipol
Phase 2 · Northwest Clinical Research Center /ID# 273480 · AbbVie · NCT07220460 FORWARD CAD IDE Study
NA · Overlake Medical Center · Shockwave Medical, Inc. · NCT06662500 Cholesterol Lowering and Residual Risk in Diabetes, Type 1
Phase 4 · NYU Langone Health · NCT05641753 Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06830044 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescent
Phase 2 · Nebraska Medicine-Bellevue · National Cancer Institute (NCI) · NCT06900595 Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Phase 3 · Northwest Clinical Research Center · Intra-Cellular Therapies, Inc. · NCT06372964 Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidin
Phase 2 · Nebraska Medicine-Bellevue · National Cancer Institute (NCI) · NCT05554393 Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown O
Phase 3 · The Asthma and Allergy Center- Site Number : 8400014 · Sanofi · NCT05263206 Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
NA · Overlake Medical Center · Eastern Cooperative Oncology Group · NCT05108298 A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Dep
Phase 2 · Northwest Clinical Research Center /ID# 277484 · AbbVie · NCT07276997 Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab
Phase 2 · Nebraska Medicine-Bellevue · NRG Oncology · NCT05327686 Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Phase 3 · Overlake Medical Center · Children's Oncology Group · NCT05235165

Look up another city

Look up another condition